QUANEX BUILDING PRODUCTS (NX) Fundamental Analysis & Valuation

NYSE:NX • US7476191041

Current stock price

19.32 USD
-0.43 (-2.18%)
Last:

This NX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. NX Profitability Analysis

1.1 Basic Checks

  • NX had positive earnings in the past year.
  • NX had a positive operating cash flow in the past year.
  • Of the past 5 years NX 4 years were profitable.
  • NX had a positive operating cash flow in each of the past 5 years.
NX Yearly Net Income VS EBIT VS OCF VS FCFNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • NX has a Return On Assets of -12.13%. This is in the lower half of the industry: NX underperforms 78.57% of its industry peers.
  • With a Return On Equity value of -32.86%, NX is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
  • The Return On Invested Capital of NX (5.46%) is worse than 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NX is significantly below the industry average of 11.89%.
Industry RankSector Rank
ROA -12.13%
ROE -32.86%
ROIC 5.46%
ROA(3y)-0.46%
ROA(5y)3.75%
ROE(3y)-5.38%
ROE(5y)3.29%
ROIC(3y)6.69%
ROIC(5y)9.3%
NX Yearly ROA, ROE, ROICNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • NX's Operating Margin of 6.52% is on the low side compared to the rest of the industry. NX is outperformed by 61.90% of its industry peers.
  • NX's Operating Margin has been stable in the last couple of years.
  • NX's Gross Margin of 27.37% is in line compared to the rest of the industry. NX outperforms 42.86% of its industry peers.
  • NX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.52%
PM (TTM) N/A
GM 27.37%
OM growth 3Y-10.87%
OM growth 5Y-0.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y3.71%
NX Yearly Profit, Operating, Gross MarginsNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

3

2. NX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NX is destroying value.
  • Compared to 1 year ago, NX has less shares outstanding
  • NX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NX is higher compared to a year ago.
NX Yearly Shares OutstandingNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NX Yearly Total Debt VS Total AssetsNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • NX has an Altman-Z score of 1.88. This is not the best score and indicates that NX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.88, NX is doing worse than 78.57% of the companies in the same industry.
  • The Debt to FCF ratio of NX is 7.45, which is on the high side as it means it would take NX, 7.45 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NX (7.45) is worse than 64.29% of its industry peers.
  • NX has a Debt/Equity ratio of 0.93. This is a neutral value indicating NX is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.93, NX is not doing good in the industry: 69.05% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 7.45
Altman-Z 1.88
ROIC/WACC0.53
WACC10.27%
NX Yearly LT Debt VS Equity VS FCFNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • NX has a Current Ratio of 2.31. This indicates that NX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.31, NX is doing good in the industry, outperforming 61.90% of the companies in the same industry.
  • NX has a Quick Ratio of 1.21. This is a normal value and indicates that NX is financially healthy and should not expect problems in meeting its short term obligations.
  • NX's Quick ratio of 1.21 is fine compared to the rest of the industry. NX outperforms 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.21
NX Yearly Current Assets VS Current LiabilitesNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. NX Growth Analysis

3.1 Past

  • The earnings per share for NX have decreased by -3.65% in the last year.
  • NX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.25% yearly.
  • Looking at the last year, NX shows a very strong growth in Revenue. The Revenue has grown by 28.35%.
  • Measured over the past years, NX shows a quite strong growth in Revenue. The Revenue has been growing by 16.63% on average per year.
EPS 1Y (TTM)-3.65%
EPS 3Y-4.83%
EPS 5Y13.25%
EPS Q2Q%-105.26%
Revenue 1Y (TTM)28.35%
Revenue growth 3Y14.58%
Revenue growth 5Y16.63%
Sales Q2Q%2.26%

3.2 Future

  • Based on estimates for the next years, NX will show a small growth in Earnings Per Share. The EPS will grow by 1.27% on average per year.
  • Based on estimates for the next years, NX will show a small growth in Revenue. The Revenue will grow by 2.03% on average per year.
EPS Next Y-10.49%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.3%
Revenue Next 2Y2.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NX Yearly Revenue VS EstimatesNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NX Yearly EPS VS EstimatesNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

7

4. NX Valuation Analysis

4.1 Price/Earnings Ratio

  • NX is valuated reasonably with a Price/Earnings ratio of 9.16.
  • Based on the Price/Earnings ratio, NX is valued cheaply inside the industry as 97.62% of the companies are valued more expensively.
  • NX is valuated cheaply when we compare the Price/Earnings ratio to 27.18, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 8.16, the valuation of NX can be described as reasonable.
  • NX's Price/Forward Earnings ratio is rather cheap when compared to the industry. NX is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.96, NX is valued rather cheaply.
Industry RankSector Rank
PE 9.16
Fwd PE 8.16
NX Price Earnings VS Forward Price EarningsNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NX is valued cheaply inside the industry as 90.48% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, NX is valued cheaply inside the industry as 95.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.35
EV/EBITDA 6.95
NX Per share dataNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.69
EPS Next 2Y1.27%
EPS Next 3YN/A

6

5. NX Dividend Analysis

5.1 Amount

  • NX has a Yearly Dividend Yield of 1.59%. Purely for dividend investing, there may be better candidates out there.
  • NX's Dividend Yield is rather good when compared to the industry average which is at 0.72. NX pays more dividend than 88.10% of the companies in the same industry.
  • NX's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.59%

5.2 History

  • The dividend of NX has a limited annual growth rate of 0.08%.
  • NX has paid a dividend for at least 10 years, which is a reliable track record.
  • NX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.08%
Div Incr Years0
Div Non Decr Years16
NX Yearly Dividends per shareNX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

5.3 Sustainability

  • The earnings of NX are negative and hence is the payout ratio. NX will probably not be able to sustain this dividend level.
  • NX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-6.13%
EPS Next 2Y1.27%
EPS Next 3YN/A
NX Yearly Income VS Free CF VS DividendNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

NX Fundamentals: All Metrics, Ratios and Statistics

QUANEX BUILDING PRODUCTS

NYSE:NX (4/14/2026, 1:13:26 PM)

19.32

-0.43 (-2.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)03-05
Earnings (Next)06-03
Inst Owners108.2%
Inst Owner Change0%
Ins Owners1.26%
Ins Owner Change10.95%
Market Cap887.37M
Revenue(TTM)1.85B
Net Income(TTM)-239.99M
Analysts86
Price Target29.33 (51.81%)
Short Float %5.55%
Short Ratio4.36
Dividend
Industry RankSector Rank
Dividend Yield 1.59%
Yearly Dividend0.32
Dividend Growth(5Y)0.08%
DP-6.13%
Div Incr Years0
Div Non Decr Years16
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.79%
Min EPS beat(2)56.47%
Max EPS beat(2)83.12%
EPS beat(4)3
Avg EPS beat(4)35.6%
Min EPS beat(4)-20.49%
Max EPS beat(4)83.12%
EPS beat(8)7
Avg EPS beat(8)494.92%
EPS beat(12)11
Avg EPS beat(12)346.29%
EPS beat(16)14
Avg EPS beat(16)266.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-2.2%
Max Revenue beat(4)1.03%
Revenue beat(8)2
Avg Revenue beat(8)-1.03%
Revenue beat(12)4
Avg Revenue beat(12)-0.88%
Revenue beat(16)7
Avg Revenue beat(16)0.12%
PT rev (1m)2.68%
PT rev (3m)2.68%
EPS NQ rev (1m)-3.03%
EPS NQ rev (3m)-10.61%
EPS NY rev (1m)-4.29%
EPS NY rev (3m)-4.29%
Revenue NQ rev (1m)0.55%
Revenue NQ rev (3m)4.02%
Revenue NY rev (1m)1.05%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 9.16
Fwd PE 8.16
P/S 0.48
P/FCF 9.35
P/OCF 5.64
P/B 1.21
P/tB N/A
EV/EBITDA 6.95
EPS(TTM)2.11
EY10.92%
EPS(NY)2.37
Fwd EY12.26%
FCF(TTM)2.07
FCFY10.69%
OCF(TTM)3.42
OCFY17.72%
SpS40.21
BVpS15.9
TBVpS-1.95
PEG (NY)N/A
PEG (5Y)0.69
Graham Number27.48
Profitability
Industry RankSector Rank
ROA -12.13%
ROE -32.86%
ROCE 6.95%
ROIC 5.46%
ROICexc 5.67%
ROICexgc 11.13%
OM 6.52%
PM (TTM) N/A
GM 27.37%
FCFM 5.14%
ROA(3y)-0.46%
ROA(5y)3.75%
ROE(3y)-5.38%
ROE(5y)3.29%
ROIC(3y)6.69%
ROIC(5y)9.3%
ROICexc(3y)7.19%
ROICexc(5y)10.09%
ROICexgc(3y)13.35%
ROICexgc(5y)17.83%
ROCE(3y)8.51%
ROCE(5y)11.84%
ROICexgc growth 3Y-23.91%
ROICexgc growth 5Y-6.21%
ROICexc growth 3Y-29.51%
ROICexc growth 5Y-7.67%
OM growth 3Y-10.87%
OM growth 5Y-0.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y3.71%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 7.45
Debt/EBITDA 3.04
Cap/Depr 60.52%
Cap/Sales 3.37%
Interest Coverage 250
Cash Conversion 70.37%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.21
Altman-Z 1.88
F-Score5
WACC10.27%
ROIC/WACC0.53
Cap/Depr(3y)69.75%
Cap/Depr(5y)69.6%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.65%
EPS 3Y-4.83%
EPS 5Y13.25%
EPS Q2Q%-105.26%
EPS Next Y-10.49%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.35%
Revenue growth 3Y14.58%
Revenue growth 5Y16.63%
Sales Q2Q%2.26%
Revenue Next Year2.3%
Revenue Next 2Y2.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y132.01%
EBIT growth 3Y2.12%
EBIT growth 5Y16.22%
EBIT Next Year38.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.45%
FCF growth 3Y16.4%
FCF growth 5Y6.37%
OCF growth 1Y6.38%
OCF growth 3Y18.95%
OCF growth 5Y10.34%

QUANEX BUILDING PRODUCTS / NX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for QUANEX BUILDING PRODUCTS?

ChartMill assigns a fundamental rating of 4 / 10 to NX.


Can you provide the valuation status for QUANEX BUILDING PRODUCTS?

ChartMill assigns a valuation rating of 7 / 10 to QUANEX BUILDING PRODUCTS (NX). This can be considered as Undervalued.


What is the profitability of NX stock?

QUANEX BUILDING PRODUCTS (NX) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUANEX BUILDING PRODUCTS (NX) stock?

The Price/Earnings (PE) ratio for QUANEX BUILDING PRODUCTS (NX) is 9.16 and the Price/Book (PB) ratio is 1.21.


What is the earnings growth outlook for QUANEX BUILDING PRODUCTS?

The Earnings per Share (EPS) of QUANEX BUILDING PRODUCTS (NX) is expected to decline by -10.49% in the next year.